|
 Provided by: ReachMD
Login or Register for additional programming information
Program Description
Asthma remains a difficult disease to treat and control, with a large portion of the patient population not receiving adequate treatment options. But next-generation therapies are targeting this inflammation by being more targeted, getting at the root of the pathways that play a larger role in the disease. Bob Baltera, chief executive officer of Amira Pharmaceuticals, tells host Bruce Japsen about developments in more targeted therapies.
 Bruce Japsen has been a healthcare business reporter for the Chicago Tribune since May of 1998. Mr. Japsen covers pharmaceutical and device makers, economic issues, managed-care companies, doctor practices and other physician issues. He has covered everything from the Vioxx-product liability trials and controversies involving the foray of Walgreens and Wal-Mart into retail medicine, to bird flu vaccine production and stem cell research. In addition to the regular healthcare business stories he writes, he has a regular Thursday column in the Tribune business section and is a regular on WGN radio and television, CBS-owned WBBM-News radio 780 and Tribune-owned CLTV. Reach his work at chicagotribune.com or follow him on Twitter.
Bob Baltera is chief executive officer is chief executive officer of San Diego-based Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and early development of compounds to treat inflammatory disease. He has nearly two decades of product management experience, including work at biotech giant Amgen Inc., where he held several senior management positions including vice president of corporate and contract manufacturing. A scientist by training, Mr. Baltera has a master's of business administration from the Anderson School at UCLA and earned his bachelor's degree in microbiology and a master's degree in genetics from the Pennsylvania State University.
ReachMD, an innovative communications company, provides thought-provoking medical news and information to healthcare practitioners. Established to help increasingly time-constrained medical providers stay abreast of new research, treatment protocols and continuing education requirements, ReachMD delivers innovative and informative radio programming via XM Satellite Radio Channel 160 and online streaming developed by healthcare professionals for healthcare professionals.
The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
RECOMMEND THIS ARTICLE
You must be logged in
to recommend articles
| 
